STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Dolby Laboratories, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Dolby Laboratories (DLB) filed a Form 144 indicating a planned sale of restricted stock. The notice covers the proposed sale of 6,164 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $407,563.68. The filing notes that 60,845,846 shares of the issuer’s common stock are outstanding.

The shares to be sold were originally acquired as restricted stock from the issuer in multiple grants between 2013 and 2021, including blocks of 2,356 shares on 12/15/2020 and 1,627 shares on 12/16/2021, all listed as fully paid in cash or not requiring additional consideration. The person on whose behalf the sale is planned represents that they are not aware of any undisclosed material adverse information about the company’s operations.

Positive
  • None.
Negative
  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Dolby Laboratories Inc

NYSE:DLB

DLB Rankings

DLB Latest News

DLB Latest SEC Filings

DLB Stock Data

6.21B
60.32M
1.35%
98.06%
1.9%
Specialty Business Services
Patent Owners & Lessors
Link
United States
SAN FRANCISCO